Cyclodextrins as templates for the presentation of protease inhibitors

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L (1996)
FEBS LETTERS 391(3): 297-301.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 1996;391(3):297-301.
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., & Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), 297-301.
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., and Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS 391, 297-301.
Schaschke, N., et al., 1996. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), p 297-301.
N. Schaschke, et al., “Cyclodextrins as templates for the presentation of protease inhibitors”, FEBS LETTERS, vol. 391, 1996, pp. 297-301.
Schaschke, N., Musiol, H.J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., Moroder, L.: Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 391, 297-301 (1996).
Schaschke, Norbert, Musiol, HJ, AssfalgMachleidt, I, Machleidt, W, RudolphBohner, S, and Moroder, L. “Cyclodextrins as templates for the presentation of protease inhibitors”. FEBS LETTERS 391.3 (1996): 297-301.
This data publication is cited in the following publications:
This publication cites the following data publications:

8 Citations in Europe PMC

Data provided by Europe PubMed Central.

Carbohydrates in peptide and protein design.
Jensen KJ, Brask J., Biopolymers 80(6), 2005
PMID: 15929028
Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, Deluca D, Pfeiler D, Schaschke N, Moroder L, Machleidt W., Biol. Chem. 384(3), 2003
PMID: 12715890
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem. Biol. 8(4), 2001
PMID: 11325588
Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L., Bioorg. Med. Chem. Lett. 10(7), 2000
PMID: 10762052
Synthesis of bivalent inhibitors of eucaryotic proteasomes.
Loidl G, Musiol HJ, Groll M, Huber R, Moroder L., J. Pept. Sci. 6(1), 2000
PMID: 10674718
Bivalency as a principle for proteasome inhibition.
Loidl G, Groll M, Musiol HJ, Huber R, Moroder L., Proc. Natl. Acad. Sci. U.S.A. 96(10), 1999
PMID: 10318898
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G, Groll M, Musiol HJ, Ditzel L, Huber R, Moroder L., Chem. Biol. 6(4), 1999
PMID: 10099130

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 8764993
PubMed | Europe PMC

Search this title in

Google Scholar